Does smoking influence Crohn's disease in the biologic era? the TABACROHN study

Inflammatory Bowel Diseases

Volumn 19, Issue 1, 2013, Pages 23-29

  Nunes, Tiago ^a,b,o   Etchevers, Maria Josefina ^a,b,o   Merino, Olga ^b,o   Gallego, Sonia ^c   García Sánchez, Valle ^d   Marín Jiménez, Ignacio ^e   Menchén, Luis ^e   Acosta, Manuel Barreiro De ^f   Bastida, Guillermo ^b,g,o   García, Sara ^h   Gento, Elena ^h   Ginard, Daniel ⁱ   Gomollón, Fernando ^j   Arroyo, Maite ^j   Monfort, David ^k   García Planella, Esther ^l   Gonzalez, Benito ^m   Loras, Carme ⁿ   Agustí, Carles ^a,b,o   Figueroa, Carolina ^a,b,o   Sans, Miquel ^a,b,o   more..

^a HOSPITAL CLÍNIC   (Spain)

^b HOSPITAL DE CRUCES   (Spain)

^c HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^d HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^e HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^f University Hospital of Santiago de Compostela   (Spain)

^g HOSPITAL UNIVERSITARIO LA FE   (Spain)

^h HOSPITAL UNIVERSITARIO DE BURGOS   (Spain)

ⁱ HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^j HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^k Brain   (Spain)

^l Hospital Sant Pau   (Spain)

^m HOSPITAL JUAN CANALEJO   (Spain)

ⁿ HOSPITAL MÚTUA DE TERRASSA   (Spain)

^o INSTITUTO DE SALUD CARLOS III   (Spain)

more..

Author keywords

Crohn's disease; Disease phenotype; Environmental factors; Inflammatory bowel disease; Smoking; Tobacco

Indexed keywords

BIOLOGICAL PRODUCT; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; BIOLOGICAL THERAPY; CROHN DISEASE; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE PREDISPOSITION; FEMALE; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ONSET AGE; PHENOTYPE; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; TOBACCO;

ADULT; BIOLOGICAL THERAPY; CROHN DISEASE; CROSS-SECTIONAL STUDIES; EUROPE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; SMOKING; YOUNG ADULT;

EID: 84873737550     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.22959     Document Type: Article

References (42)

1. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology. 1998;115:182-205.
2. Scaldaferri F, Fiocchi C. Inflammatory bowel disease: progress and current concepts of etiopathogenesis. J Dig Dis. 2007;8:171-178.
3. Danese S, Sans M, Fiocchi C. Inflammatory bowel disease: the role of environmental factors. Autoimmun Rev. 2004;3:394-400.
4. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004;126:1504-1517.
5. Somerville KW, Logan RF, Edmond M, et al. Smoking and Crohn's disease. Br Med J (Clin Res Ed). 1984;289:954-956.
6. Tobin MV, Logan RF, Langman MJ, et al. Cigarette smoking and inflammatory bowel disease. Gastroenterology. 1987;93:316-321.
7. Calkins BM. A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci. 1989;34:1841-1854.
8. Mahid SS, Minor KS, Soto RE, et al. Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc. 2006;81:1462-1471.
9. Johnson GJ, Cosnes J, Mansfield JC. Review article: smoking cessation as primary therapy to modify the course of Crohn's disease. Ali ment Pharmacol Ther. 2005;21:921-931.
10. Cosnes J. Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice. Best Pract Res Clin Gastroenterol. 2004;18:481-496.
11. McGilligan VE, Wallace JM, Heavey PM, et al. Hypothesis about mechanisms through which nicotine might exert its effect on the inter dependence of inflammation and gut barrier function in ulcerative colitis. Inflamm Bowel Dis. 2007;13:108-115.
12. Franke A, McGovern DP, Barrett JC, et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet. 2010;42:1118-1125.
13. Carbonnel F, Jantchou P, Monnet E, et al. Environmental risk factors in Crohn's disease and ulcerative colitis: an update. Gastroenterol Clin Biol. 2009;33(Suppl 3):S145-S157.
14. King TE Jr, Savici D, Campbell PA. Phagocytosis and killing of Listeria monocytogenes by alveolar macrophages: smokers versus non-smokers. J Infect Dis. 1988;158:1309-1316.
15. Brant SR, Picco MF, Achkar JP, et al. Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn's disease phenotypes. Inflamm Bowel Dis. 2003;9:281-289.
16. Breuer-Katschinski BD, Hollander N, Goebell H. Effect of cigarette smoking on the course of Crohn's disease. Eur J Gastroenterol Hepatol. 1996;8:225-228.
17. Cosnes J, Carbonnel F, Beaugerie L, et al. Effects of cigarette smoking on the long-term course of Crohn's disease. Gastroenterology. 1996;110:424-431.
18. Cosnes J, Carbonnel F, Carrat F, et al. Effects of current and former cigarette smoking on the clinical course of Crohn's disease. Aliment Pharmacol Ther. 1999;13:1403-1411.
19. Cottone M, Rosselli M, Orlando A, et al. Smoking habits and recurrence in Crohn's disease. Gastroenterology. 1994;106:643-648.
20. Kane SV, Flicker M, Katz-Nelson F. Tobacco use is associated with accelerated clinical recurrence of Crohn's disease after surgically induced remission. J Clin Gastroenterol. 2005;39:32-35.
21. Lindberg E, Jarnerot G, Huitfeldt B. Smoking in Crohn's disease: effect on localisation and clinical course. Gut. 1992;33:779-782.
22. Louis E, Michel V, Hugot JP, et al. Early development of stricturing or penetrating pattern in Crohn's disease is influenced by disease location, number of flares, and smoking but not by NOD2/CARD15 genotype. Gut. 2003;52:552-557.
23. Moskovitz D, McLeod RS, Greenberg GR, et al. Operative and environmental risk factors for recurrence of Crohn's disease. Int J Colorectal Dis. 1999;14:224-226.
24. Reese GE, Nanidis T, Borysiewicz C, et al. The effect of smoking after surgery for Crohn's disease: a meta-analysis of observational studies. Int J Colorectal Dis. 2008;23:1213-1221.
25. Russel MG, Volovics A, Schoon EJ, et al. Inflammatory bowel disease: is there any relation between smoking status and disease presentation? European Collaborative IBD Study Group. Inflamm Bowel Dis. 1998;4: 182-186.
26. Sutherland LR, Ramcharan S, Bryant H, et al. Effect of cigarette smoking on recurrence of Crohn's disease. Gastroenterology. 1990;98(5 Pt 1):1123-1128.
27. Yamamoto T, Keighley MR. The association of cigarette smoking with a high risk of recurrence after ileocolonic resection for ileocecal Crohn's disease. Surg Today. 1999;29:579-580.
28. Yamamoto T, Keighley MR. Smoking and disease recurrence afteroperation for Crohn's disease. Br J Surg. 2000;87:398-404.
29. Picco MF, Bayless TM. Tobacco consumption and disease duration are associated with fistulizing and stricturing behaviors in the first 8 years of Crohn's disease. Am J Gastroenterol. 2003;98:363-368.
30. Rocca G, Astegiano M, Sostegni R, et al. Effect of current smoking on the clinical presentation, medical therapy, and surgical therapy of Crohn's disease. Gastroenterology. 1997;112:A1074.
31. Bustamante M, Nos P, Hoyos M, et al. Relationship between smoking and colonic involvement in inflammatory bowel disease. Rev Esp Enferm Dig. 1998;90:833-840.
32. Holdstock G, Savage D, Harman M, et al. Should patients with inflammatory bowel disease smoke? Br Med J (Clin Res Ed). 1984;288:362.
33. Aldhous MC, Drummond HE, Arnott DR, et al. Effect of smoking habit and load on clinical presentation and progression in Crohn's disease and ulcerative colitis. BSG. 2005;Abstract A2.
34. Parsi MA. Does smoking decrease the response to infliximab in patients with Crohn's disease? Inflamm Bowel Dis. 2008;14(Suppl 2): S18-S19.
35. Parsi MA, Achkar JP, Richardson S, et al. Predictors of response to infliximab in patients with Crohn's disease. Gastroenterology. 2002; 123:707-713.
36. Arnott ID, McNeill G, Satsangi J. An analysis of factors influencing shortterm and sustained response to infliximab treatment for Crohn's disease. Aliment Pharmacol Ther. 2003;17:1451-1457.
37. Mahid SS, Minor KS, Stevens PL, et al. The role of smoking in Crohn's disease as defined by clinical variables. Dig Dis Sci. 2007; 52:2897-2903.
38. Cosnes J, Cattan S, Blain A, et al. Long-term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis. 2002;8:244-250.
39. Benoni C, Nilsson A. Smoking habits in patients with inflammatory bowel disease. Scand J Gastroenterol. 1984;19:824-830.
40. Aldhous MC, Drummond HE, Anderson N, et al. Does cigarette smoking influence the phenotype of Crohn's disease? Analysis using the Montreal classification. Am J Gastroenterol. 2007;102:577-588.
41. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19(Suppl A):5-36.
42. Domenech E, Carrion S, Garcia-Planella E, et al. Smoking status and response to thiopurines in steroid-dependent inflammatory bowel disease. Inflamm Bowel Dis. 2011;17:971-975.